会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 3. 发明授权
    • Method for the antibiotic coating of bodies with interconnecting microcavities as well as coated bodies and their usage
    • 具有互连微腔以及涂层体的物体的抗生素涂层方法及其用途
    • US07358232B2
    • 2008-04-15
    • US10174682
    • 2002-06-19
    • Sebastian VogtMatthias SchnabelrauchKlaus-Dieter Kühn
    • Sebastian VogtMatthias SchnabelrauchKlaus-Dieter Kühn
    • A61K31/70C07H15/02
    • A61K9/0024
    • The invention relates to a method for the antibiotic coating of bodies with interconnecting microcavities as well as bodies coated this way and their usage. The invented method is characterized in that in the microcavities of non-metallic bodies an aqueous solution 1, which contains at least one easily water-soluble antibiotic component from the groups of the aminoglycoside antibiotics, the tetracycline antibiotics, the lincosamide antibiotics and the 4-quinolone antibiotics, and an aqueous solution 2, which contains at least one easily water-soluble amphiphilic component from the groups of the alkyl sulfates, alkyl sulfonates, alkylaryl sulfates, dialkylaryl sulfates, alkylaryl sulfonates, dialkylaryl sulfonates, cycloalkyl sulfates, cycloalkyl sulfonates, alkylcycloalkyl sulfates, are introduced, wherein between the introduction of solutions 1 and 2 the water is basically removed through vaporization and/or evaporation, and whereby from the components of solutions 1 and 2 in the microcavities a deposit is formed, which is sparingly soluble in water.
    • 本发明涉及一种用于具有互连微腔的物体的抗生素包被的方法以及这种方式涂覆的物体及其用途。 本发明的方法的特征在于,在非金属体的微腔中,含有来自氨基糖苷类抗生素组的至少一种容易水溶性抗生素成分的水溶液1,四环素抗生素,林可素类抗生素和4- 喹诺酮抗生素和水溶液2,其含有至少一种容易水溶性的两亲成分,分别为烷基硫酸盐,烷基磺酸盐,烷基芳基硫酸盐,二烷基芳基硫酸盐,烷基芳基磺酸盐,二烷基芳基磺酸盐,环烷基硫酸盐,环烷基磺酸盐,烷基环烷基 硫酸盐,其中在引入溶液1和2之间基本上通过蒸发和/或蒸发除去水,并且由此在微腔中的溶液1和2的组分中形成沉积物,其沉积物微溶于水 。
    • 4. 发明授权
    • Antibiotic(s) preparation with retarding active ingredient release
    • 具有延缓活性成分释放的抗生素制剂
    • US06913764B2
    • 2005-07-05
    • US10100839
    • 2002-03-19
    • Sebastian VogtMatthias SchnabelrauchKlaus-Dieter Kühn
    • Sebastian VogtMatthias SchnabelrauchKlaus-Dieter Kühn
    • A61K9/00A61K9/10A61K9/14A61K9/20A61K9/22A61K9/70A61K31/00A61K31/70A61K31/7036A61K31/726A61K45/06A61K45/08A61K47/02A61K47/14A61K47/16A61K47/20A61K47/24A61L27/54A61L31/16A61K2/02
    • A61K31/7036A61K9/0024A61K9/2013A61K31/00A61L27/54A61L2300/406A61L2300/602A61L2300/802
    • The present invention concerns an antibiotic/antibiotics preparation for resorbable and non-resorbable implants for human and veterinary medicine, for the treatment of local microbial infections in hard and soft tissue. The invented antibiotic/antibiotics preparation is a mixture consisting of at least one amphiphilic component of a representative of the alkyl sulfates, aryl sulfates, alkylaryl sulfates, cycloalkyl sulfates, alkylcycloalkyl sulfates, alkyl sulfamates, cycloalkyl sulfamates, alkylcycloalkyl sulfamates, aryl sulfamates, alkylaryl sulfamates, alkyl sulfonates, fatty acid-2-sulfonates, aryl sulfonates, alkylaryl sulfonates, cycloalkyl sulfonates, alkylcycloalkyl sulfonates, alkyl disulfates, cycloalkyl disulfates, alkyl disulfonates, cycloalkyl disulfonates, aryl disulfonates, alkylaryl disulfonates, aryl trisulfonates and alkylaryl trisulfonates as well as at least one antibiotic component from the group of aminoglycoside antibiotics, lincosamide antibiotics, 4-quinolone antibiotics and tetracycline antibiotics, and if need be at least one anhydrous organic auxiliary component and if need be at least one inorganic auxiliary component and if need be at least one biologically active component. The antibiotic/antibiotics preparation of the invention has a retarding active ingredient release.
    • 本发明涉及用于人和兽医药物的可再吸收和不可吸收植入物的抗生素/抗生素制剂,用于治疗硬组织和软组织中的局部微生物感染。 本发明的抗生素/抗生素制剂是由至少一种代表烷基硫酸盐,芳基硫酸盐,烷基芳基硫酸盐,环烷基硫酸盐,烷基环烷基硫酸盐,氨基磺酸烷基酯,环烷基磺酸盐,烷基环烷基氨基磺酸盐,芳基亚磺酸盐,烷基芳基亚磺酸盐 烷基磺酸盐,脂肪酸-2-磺酸盐,芳基磺酸盐,烷基芳基磺酸盐,环烷基磺酸盐,烷基环烷基磺酸盐,烷基二硫酸盐,环烷基二硫酸盐,烷基二磺酸盐,环烷基二磺酸盐,芳基二磺酸盐,烷基芳基二磺酸盐,芳基三磺酸盐和烷基芳基三磺酸盐以及 至少一种来自氨基糖苷类抗生素的抗生素成分,林可素类抗生素,4-喹诺酮类抗生素和四环素抗生素,如果需要至少一种无机有机辅助成分,如果需要至少一种无机辅助成分,如果需要至少一种 生物活性成分 ent。 本发明的抗生素/抗生素制剂具有缓释活性成分释放。
    • 7. 发明授权
    • Implant material
    • 植入材料
    • US07858109B2
    • 2010-12-28
    • US11675127
    • 2007-02-15
    • Klaus-Dieter KühnSebastian Vogt
    • Klaus-Dieter KühnSebastian Vogt
    • A61F2/00A61K31/70A61K38/16A61K31/496
    • A61K9/0024A61K9/2072A61K9/70A61K31/7036A61L27/54A61L2300/406
    • Form bodies, which can be rotationally-symmetrical or irregularly-shaped, consist of at least one member of the group of the antibiotic salts, gentamicin myristate, gentamicin palmitate, gentamicin stearate, tobramycin myristate, tobramycin palmitate, tobramycin stearate, amikacin myristate, amikacin palmitate, amikacin stearate, vancomycin palmitate, vancomycin stearate, ramoplanin palmitate, ramoplanin stearate, levofloxacin palmitate, levofloxacin stearate, ofloxacin palmitate, ofloxacin stearate, moxifloxacin palmitate, moxifloxacin stearate, clindamycin palmitate, and clindamycin stearate. A medical device for implantation, in which the form bodies are arranged on a biodegradable filament at a distance of 1 mm to 25 mm as well as a method for the manufacture of the medical device and the use of the form bodies or the medical device to treat chronic osteomyelitis are described.
    • 可以旋转对称或不规则形状的成形体由至少一种抗生素盐,庆大霉素,肉豆蔻酸庆大霉素,庆大霉素棕榈酸酯,肉豆蔻酸庆大霉素,妥布霉素棕榈酸酯,妥布霉素棕榈酸酯,肉豆蔻酸阿米卡星,阿米卡星 棕榈酸盐,阿米卡星硬脂酸盐,万古霉素棕榈酸酯,拉莫洛维林棕榈酸酯,拉莫洛宁硬脂酸酯,左氧氟沙星棕榈酸酯,左氧氟沙星硬脂酸酯,氧氟沙星棕榈酸酯,氧氟沙星硬脂酸酯,莫西沙星棕榈酸酯,莫西沙星硬脂酸酯,克林霉素棕榈酸酯和克林霉素硬脂酸酯。 一种用于植入的医疗装置,其中,所述成形体以1mm至25mm的距离布置在生物可降解的长丝上,以及用于制造所述医疗装置的方法以及所述成形体或所述医疗装置的使用 描述治疗慢性骨髓炎。
    • 8. 发明授权
    • Polymethylmethacrylate bone cement
    • 聚甲基丙烯酸甲酯骨水泥
    • US07655706B2
    • 2010-02-02
    • US11447807
    • 2006-06-06
    • Klaus-Dieter KühnSebastian Vogt
    • Klaus-Dieter KühnSebastian Vogt
    • A61F2/28
    • A61L27/50A61L24/001A61L24/06A61L27/16A61L2430/02C08L33/12
    • A polymethylmethacrylate bone cement with a liquid monomer component and a solid component contains in the monomer liquid, for example, 0.001-1.00 mass percent of a dye or dye mixture that is insoluble or poorly soluble in methacrylic acid methylester and, for example, 0.001-2.00 mass percent of a synthetically produced, protein-free, hydrophobic, low molecular or oligomeric solubilizer for the dye or dye mixture. The solubilizer preferably is liquid or pasty at room temperature. The monomer liquid is translucent at room temperature. Preferably, 0.001-1.00 mass percent of a dye or dye mixture that is insoluble or poorly soluble in methacrylic acid methylester and, preferably, 0.001-2.00 mass percent of a synthetically produced, protein-free, hydrophobic, low molecular or oligomeric solubilizer that is liquid or pasty at room temperature are homogeneously dissolved in the polymethacrylate or polymethylacrylate of the powder component.
    • 具有液体单体组分和固体组分的聚甲基丙烯酸甲酯骨粘固剂在单体液体中含有例如0.001-1.00质量%的不溶于或难溶于甲基丙烯酸甲酯的染料或染料混合物,例如, 用于染料或染料混合物的合成产生的无蛋白质,疏水性,低分子或低聚增溶剂的2.00质量%。 增溶剂在室温下优选为液体或糊状。 单体液体在室温下是半透明的。 优选0.001〜1.00质量%的不溶于或难溶于甲基丙烯酸甲酯的染料或染料混合物,优选0.001-2.00质量%的合成产生的无蛋白质,疏水性,低分子或低聚物的增溶剂,其为 液体或糊状物均匀地溶解在粉末组分的聚甲基丙烯酸酯或聚甲基丙烯酸甲酯中。